World Evidence Pricing and Access Congress

About World Evidence Pricing and Access Congress

The World Evidence, Pricing and Access Congress 2027 returns as Europe’s largest meeting point for global leaders in pharma, biotech, and HTA - and now expands its global footprint with an exciting new USA launch event in September 2027.

With over 1,600 attendees, 250 expert speakers, and 10 focused content tracks, the Congress is the must-attend event for anyone working at the intersection of access, pricing, and real-world evidence.

Join industry leaders from top 50 pharma companies including Novartis, Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Pfizer, and Merck, who will take the stage to share cutting-edge strategies in pricing, market access, and value demonstration. From the future of sustainable access to innovative payment models, our sessions will explore the most pressing challenges shaping the field - across both European and US markets.

We are proud to partner with leading solution providers including ZS, Parexel, Lifescience Dynamics, Valid Insight, Genesis Research, Partners4Access and more, who will be showcasing cutting-edge tools and strategies driving the future of access on both sides of the Atlantic.

World EPA Congress Europe: 2 - 3 March 2027 | RAI Convention Center, Amsterdam World EPA Congress USA : 14 - 15 September 2027 | Hynes Convention Center, Boston

#WorldEPACongress #EPA #MarketAccess #HTA #HEOR

Address

• Headquarters

  RAI Congress CentreAmsterdamNoord-Holland, Netherlands